Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study
The aim of this study was to evaluate the efficacy of two antifungal prophylaxis regimens in liver transplant recipients. One hundred and twenty-nine consecutive recipients were randomized to receive sequential treatment with intravenous liposomal amphotericin B + oral itraconazole, intravenous fluc...
Saved in:
| Published in | Transplant international Vol. 15; no. 7; p. 341 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Groningen
Frontiers Media SA
01.07.2002
|
| Online Access | Get full text |
| ISSN | 0934-0874 1432-2277 |
| DOI | 10.1007/s00147-002-0431-z |
Cover
| Abstract | The aim of this study was to evaluate the efficacy of two antifungal prophylaxis regimens in liver transplant recipients. One hundred and twenty-nine consecutive recipients were randomized to receive sequential treatment with intravenous liposomal amphotericin B + oral itraconazole, intravenous fluconazole + oral itraconazole, or intravenous and oral placebo. Frequency and incidence of mycotic colonization, local and systemic infection of mycotic origin, causes of death, and possible risk factors for mycotic infection were evaluated. The incidence of mycotic colonization was higher in the placebo group (P<0.01), but there was no significant difference in the incidence of infection between the three groups. Pre-transplant colonization, severity of liver disease, and graft rejection were all risk factors for the development of fungal infection. The routine use of antifungal prophylaxis for all liver transplant recipients does not seem to be justified. |
|---|---|
| AbstractList | The aim of this study was to evaluate the efficacy of two antifungal prophylaxis regimens in liver transplant recipients. One hundred and twenty-nine consecutive recipients were randomized to receive sequential treatment with intravenous liposomal amphotericin B + oral itraconazole, intravenous fluconazole + oral itraconazole, or intravenous and oral placebo. Frequency and incidence of mycotic colonization, local and systemic infection of mycotic origin, causes of death, and possible risk factors for mycotic infection were evaluated. The incidence of mycotic colonization was higher in the placebo group ( P<0.01), but there was no significant difference in the incidence of infection between the three groups. Pre-transplant colonization, severity of liver disease, and graft rejection were all risk factors for the development of fungal infection. The routine use of antifungal prophylaxis for all liver transplant recipients does not seem to be justified.The aim of this study was to evaluate the efficacy of two antifungal prophylaxis regimens in liver transplant recipients. One hundred and twenty-nine consecutive recipients were randomized to receive sequential treatment with intravenous liposomal amphotericin B + oral itraconazole, intravenous fluconazole + oral itraconazole, or intravenous and oral placebo. Frequency and incidence of mycotic colonization, local and systemic infection of mycotic origin, causes of death, and possible risk factors for mycotic infection were evaluated. The incidence of mycotic colonization was higher in the placebo group ( P<0.01), but there was no significant difference in the incidence of infection between the three groups. Pre-transplant colonization, severity of liver disease, and graft rejection were all risk factors for the development of fungal infection. The routine use of antifungal prophylaxis for all liver transplant recipients does not seem to be justified. The aim of this study was to evaluate the efficacy of two antifungal prophylaxis regimens in liver transplant recipients. One hundred and twenty-nine consecutive recipients were randomized to receive sequential treatment with intravenous liposomal amphotericin B + oral itraconazole, intravenous fluconazole + oral itraconazole, or intravenous and oral placebo. Frequency and incidence of mycotic colonization, local and systemic infection of mycotic origin, causes of death, and possible risk factors for mycotic infection were evaluated. The incidence of mycotic colonization was higher in the placebo group (P<0.01), but there was no significant difference in the incidence of infection between the three groups. Pre-transplant colonization, severity of liver disease, and graft rejection were all risk factors for the development of fungal infection. The routine use of antifungal prophylaxis for all liver transplant recipients does not seem to be justified. |
| Author | Baldassarri, Rubia Biancofiore, Gianni Filipponi, Franco Romanelli, Anna Catalano, Gabriele Mosca, Franco Bindi, Maria L Vagelli, Antonio |
| Author_xml | – sequence: 1 givenname: Gianni surname: Biancofiore fullname: Biancofiore, Gianni – sequence: 2 givenname: Maria surname: Bindi middlename: L fullname: Bindi, Maria L – sequence: 3 givenname: Rubia surname: Baldassarri fullname: Baldassarri, Rubia – sequence: 4 givenname: Anna surname: Romanelli fullname: Romanelli, Anna – sequence: 5 givenname: Gabriele surname: Catalano fullname: Catalano, Gabriele – sequence: 6 givenname: Franco surname: Filipponi fullname: Filipponi, Franco – sequence: 7 givenname: Antonio surname: Vagelli fullname: Vagelli, Antonio – sequence: 8 givenname: Franco surname: Mosca fullname: Mosca, Franco |
| BookMark | eNpdj01LAzEYhINUsK3-AG_Bg7fom69N1lspfkHBS49CyWYTTUmTdbMr1l_vgp48Dcw8DDMLNEs5OYQuKdxQAHVbAKhQBIAREJyS7xM0p4IzwphSMzSHmgsCWokztChlDxOoJczR6yoNwY_pzUTc9bl7P0bzFQoOCcfw6Xo89CaVLpo04N7Z0AWXhnKHDZ78Nh_Ct2vxFFvXZGJzGvoc42SVYWyP5-jUm1jcxZ8u0fbhfrt-IpuXx-f1akM6qSUx0rZgmoZy1RhfAWtrUdG60l57b42rWGMbR23LPEjJGtkKDVypylXeaS74El3_1k4HPkZXht0hFOviNNrlsewUrSmvpZzAq3_gPo99mqbtGK2lZlxL_gOxgGaA |
| ContentType | Journal Article |
| Copyright | Copyright Springer-Verlag 2002 |
| Copyright_xml | – notice: Copyright Springer-Verlag 2002 |
| DBID | 7QO 7T5 8FD FR3 H94 K9. P64 7X8 |
| DOI | 10.1007/s00147-002-0431-z |
| DatabaseName | Biotechnology Research Abstracts Immunology Abstracts Technology Research Database Engineering Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitle | Biotechnology Research Abstracts Technology Research Database AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Biotechnology Research Abstracts |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1432-2277 |
| ExternalDocumentID | 707925561 |
| GroupedDBID | --- .3N .86 .GA .GJ .Y3 05W 10A 123 1OC 1SB 29Q 2VQ 31~ 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5RE 5VS 66C 6NX 702 7PT 7QO 7T5 8-0 8-1 8-3 8-4 8-5 8FD 8UM 930 9T4 A01 A03 AAESR AAEVG AAIAL AAMMB AAONW AAZKR ABCQN ABCUV ABLJU ABOCM ABPVW ACAHQ ACGFS ACIWK ACMXC ACPOU ACPRK ACXQS ADBBV ADEOM ADIMF ADIYS ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEFGJ AEIMD AENEX AFBPY AFEBI AFGKR AFRAH AFZJQ AGXDD AHACP AHBYD AHMBA AHSBF AIACR AIDQK AIDYY AIURR AJAOE ALAGY ALMA_UNASSIGNED_HOLDINGS AMBMR AMKLP AMYDB ATUGU AZBYB AZVAB BAFTC BGNMA BHBCM BMXJE BROTX BRXPI BY8 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DL5 DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD F00 F01 F04 F5P FR3 FUBAC G-S G.N GODZA GROUPED_DOAJ H.X H94 HG6 HZI HZ~ I09 IX1 J0M K48 K9. KBYEO KDC KOV KOW LAS LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M4Y MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NU0 O66 O9- OIG OK1 P19 P2P P2W P2X P2Z P4B P4D P64 PGMZT PQQKQ Q.N Q11 QB0 QOS R.K ROL RPX RX1 SDH SMD SOJ SUPJJ TSK TSV U2A UB1 VC2 W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WIN WJK WOHZO WQJ WVDHM WXI XG1 ZZTAW ~IA ~WT 7X8 |
| ID | FETCH-LOGICAL-p585-a5cd0abb137baf602d9461968f8ffcae62bcbe1cd2f0552b5d4803776e6fe8343 |
| ISSN | 0934-0874 |
| IngestDate | Thu Sep 04 22:54:01 EDT 2025 Sat Aug 23 13:21:17 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-p585-a5cd0abb137baf602d9461968f8ffcae62bcbe1cd2f0552b5d4803776e6fe8343 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| PQID | 219582385 |
| PQPubID | 29792 |
| ParticipantIDs | proquest_miscellaneous_71913955 proquest_journals_219582385 |
| PublicationCentury | 2000 |
| PublicationDate | 20020701 |
| PublicationDateYYYYMMDD | 2002-07-01 |
| PublicationDate_xml | – month: 07 year: 2002 text: 20020701 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | Groningen |
| PublicationPlace_xml | – name: Groningen |
| PublicationTitle | Transplant international |
| PublicationYear | 2002 |
| Publisher | Frontiers Media SA |
| Publisher_xml | – name: Frontiers Media SA |
| SSID | ssj0002850 |
| Score | 1.605288 |
| Snippet | The aim of this study was to evaluate the efficacy of two antifungal prophylaxis regimens in liver transplant recipients. One hundred and twenty-nine... |
| SourceID | proquest |
| SourceType | Aggregation Database |
| StartPage | 341 |
| Title | Antifungal prophylaxis in liver transplant recipients: a randomized placebo-controlled study |
| URI | https://www.proquest.com/docview/219582385 https://www.proquest.com/docview/71913955 |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1432-2277 dateEnd: 20050518 omitProxy: true ssIdentifier: ssj0002850 issn: 0934-0874 databaseCode: U2A dateStart: 19970101 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0934-0874 databaseCode: DR2 dateStart: 19970101 customDbUrl: isFulltext: true eissn: 1432-2277 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002850 providerName: Wiley-Blackwell |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA_rCeKL-Inn-ZEH8WXp0aZJWn1b9dZD7k5Ye7APQknaBnr02nU_QPbP8i90Ju02PVZEfSklQ0ua-TUzSX4zQ8hrKYzhLDCeMSEsUHgWekrmcKejKIuLOFcMY4fPL-TpJf88F_PR6OeAtbRZ6-Ns-9u4kv_RKrSBXjFK9h80278UGuAe9AtX0DBc_0rHE2T6wN-K0VTLBgasUj9KS3CtkG6B9R_q1aKCwRtjEotFaVkTNrwZJHlzXW7B37S0LN14HWu9giaXdPZqYNLaN5XDPUS3xw7ogW_pWLufSiyF5IR1XnaBQaUa99vN71WVg--ulm20-2yjy95IzJprhQycsmVdtjW---0JR2VtATXFNAxY1NsePKnx18lwCzLknh-3VXqOi3YC5iHzGOtKu-xmaDFAYjSYbsM2adaeGWiZH1hVjUNvsFPgJ3lbZ_N25_wXX9Lp5dlZmpzMk5tSa-IxfSDmaAveLL57WKkMT_S7si23yG0WSYlVMz7OXMoyFtuqwP237U7SfZu49mZ_9uy_dWqS--RetxqhkxZaD8ioqB-SO-cd3-IR-eYQRgcIo2VNLcKoQxh1CHtHFXX4ovv4ohZfj0kyPUk-nHpdPQ5vAYtKT4ks95XWQRhpZaTP8rcclt8yNrExmSok05kugixnxheCaZHz2A-jSBbSFHHIwyfkoG7q4imhICs4iDWsD7jKtM51zLkSgfR1qBU_JEe7gUm7_22VMsyLBB6mOCSveilMhnjCBYhsNqs0CjDLrRDP_vj8EbnrkPqcHKyXm-IFuJZr_dLq8hfcBoH- |
| linkProvider | Wiley-Blackwell |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antifungal+prophylaxis+in+liver+transplant+recipients%3A+a+randomized+placebo-controlled+study&rft.jtitle=Transplant+international&rft.au=Biancofiore%2C+Gianni&rft.au=Bindi%2C+Maria+L&rft.au=Baldassarri%2C+Rubia&rft.au=Romanelli%2C+Anna&rft.date=2002-07-01&rft.pub=Frontiers+Media+SA&rft.issn=0934-0874&rft.eissn=1432-2277&rft.volume=15&rft.issue=7&rft.spage=341&rft_id=info:doi/10.1007%2Fs00147-002-0431-z&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=707925561 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0934-0874&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0934-0874&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0934-0874&client=summon |